制定癌症恶病质治疗路径
Developing a path forward in cancer cachexia
生物技术与制药领域的最新动态
Developing a path forward in cancer cachexia
What Does Agilent Technologies, Inc.'s (NYSE:A) Share Price Indicate? - Yahoo Finance
The next leap in Alzheimer’s R&D is coming, but not around the corner
10x Genomics (TXG) Price Target Increased by 10.47% to 16.66 - Nasdaq
10x Genomics Expands Flex Lineup with High-Throughput Single-Cell Assay Launch - MSN
How Lonza Group AG (Common Stock) (LO3A) stock reacts to stronger dollar - Portfolio Risk Report & Free Long-Term Investment Growth Plans - newser.com
10x Genomics (TXG): Assessing Valuation After Recent 34% Share Price Rise - simplywall.st
Is Illumina Inc. (ILU) stock a buy on weakness - Portfolio Performance Report & Accurate Buy Signal Alerts - newser.com
10x Genomics Expands Flex Lineup with High-Throughput Single-Cell Assay Launch - Yahoo Finance
10x Genomics GC Who Led Rule Of Law Effort To Retire In '26 - Law360
There's Reason For Concern Over 10x Genomics, Inc.'s (NASDAQ:TXG) Massive 42% Price Jump - simplywall.st
Republican push to make U.S. census surveys voluntary alarms statisticians
From Content Creators to Communication Partners: The Role of Motion in Scientific Storytelling
The Zacks Analyst Blog Highlights NVIDIA, Micron Technology and Thermo Fisher Scientific - Nasdaq
Is Agilent Technologies Inc. (AG8) stock prepared for digital transition - Volume Spike & Safe Capital Growth Tips - newser.com
How Waters Corporation stock correlates with oil markets - Gap Up & Daily Profit Maximizing Trade Tips - newser.com
Agilent Technologies (A): Is the Stock Undervalued After Recent Momentum Cools? - simplywall.st
Is that pharma influencer human or AI?
10x Genomics Announces Chief Legal Officer Retirement - TipRanks
Obituary information for Kathleen M. Roche - Cartmell Davis Funeral Home